A Randomised, Double Blind, Double Dummy, Active Comparator and Placebo Controlled Confirmative Non-inferiority Trial of FP187 Compared to Fumaderm in Moderate to Severe Plaque Psoriasis
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 10 Aug 2016
At a glance
- Drugs Dimethyl fumarate (Primary) ; Calcium monoethyl fumarate/dimethyl fumarate/magnesium monoethyl fumarate/zinc monoethyl fumarate
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Forward Pharma
- 08 Aug 2016 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 02 Feb 2016 Planned initiation date changed from 1 Sep 2013 to 1 Jun 2016, according to ClinicalTrials.gov record.
- 05 Mar 2015 Planned End Date changed from 1 Aug 2014 to 1 Jun 2017 as reported by ClinicalTrials.gov record.